- Staat
- AK
- Alter
- 11,0
- Geschlecht
- F
- Eingang
- 27.01.2022
- Impfdatum
- 27.01.2022
- Beginn
- 27.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Fall
Loss of consciousness
Symptomtext
Child received vaccines and sat for a minute or so then stood up and passed out, falling to the floor. Child assisted to a sitting position as soon as she came around. sat for 10 minutes before attempting to get up. No known injuries at this time
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Loss of consciousness
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- ME
- Alter
- 13,0
- Geschlecht
- F
- Eingang
- 02.12.2021
- Impfdatum
- 14.09.2021
- Beginn
- 14.09.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Anaphylactic reaction
Fatigue
Product administered to patient of inappropriate age
Pyrexia
Symptomtext
Menactra was given early--should not have been until she turned 16. Pt went into anaphylaxis within 15 minutes after vaccines and first depo-provera injection were administered. She was given an Epi-Pen and monitored in the office while EMS was activated. They arrived 7 minutes later and pt was taken to the ER. She was monitored there for 4 hours and did not go back into anaphylaxis and was released. She had fevers off and on for the next week and significant fatigue, and followed-up in my office on 9/15/21, 9/17/21, 9/22/21, 10/1/21, 10/4/21, and 10/21/21 for symptoms thought to be related to be the episode.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Anaphylactic reaction
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- dysmenorrhea, knee pain
- Andere Medikamente
- Depo-Provera, Multivitamin, Menactra, Flu vaccine, and Gardasil
- Allergien
- none at the time
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 14,0
- Geschlecht
- F
- Eingang
- 15.10.2021
- Impfdatum
- 14.10.2021
- Beginn
- 14.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Dizziness
Pallor
Syncope
Symptomtext
pt fainted after 4th vaccine which happened to be HPV vaccine. pt felt a little light headed for about 10 minutes then began to feel better. pt slightly pale for about 10 minutes. after 10 minutes, pt feeling well, awake, alert, oriented to person p lace and time
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- back pain
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- NO known allergies
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 17,0
- Geschlecht
- F
- Eingang
- 13.10.2021
- Impfdatum
- 23.09.2021
- Beginn
- 23.09.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Incoherent
Seizure
Urinary incontinence
Symptomtext
Patient received MCV4 vaccine at approximately 2:15pm. At about 2:20pm, she had a seizure and urinated on the floor. Paramedics accessed the patient and she was still not coherent. She was then transported to Hospital.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Seizure
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- N/A
- Andere Medikamente
- N/A
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- VA
- Alter
- 12,0
- Geschlecht
- F
- Eingang
- 27.07.2021
- Impfdatum
- 26.07.2021
- Beginn
- 26.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Fall
Feeling hot
Loss of consciousness
Pain in extremity
Symptomtext
Client said I feel hot I asked her to put her headdown, she raised back up said she felt okay then slumped forward in small confines of mobile unit, slid off stool to floor, sitting on one of her feet. Picked her up put her back on stool and she passed out again, we then put ice back on her forehead and put her on the couch in the mobile unit. (Vaso vagal reaction) 15 minutes later feeling fine except complaining of her foot being sore
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Loss of consciousness
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- None reported until after vaccination mother reports passed out after hpv vaccination
- Andere Medikamente
- none reported
- Allergien
- None
- Vorherige Impfungen
- passed out afterhpv vaccine in June
- Staat
- -
- Alter
- 18,0
- Geschlecht
- F
- Eingang
- 30.06.2021
- Impfdatum
- 29.06.2021
- Beginn
- 29.06.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Dizziness
Hypoacusis
Hypoaesthesia
Loss of consciousness
Musculoskeletal stiffness
Seizure
Swollen tongue
Tremor
Symptomtext
Patient stated at time of vaccination that she does sometimes get dizzy and faint during vaccines. After administration, she said she felt fine & sat near pharmacy. I went to give her a record card & noticed she didn't look well. I asked her if she felt ok; she said she felt very dizzy & then passed out. I ran out and caught her. She was shaking a bit too kind of like a seizure. One tech called EMS & one tech helped me. She woke up & said she was fine and then passed out again Again woke up, then said felt her tongue swelling, I ran to get an EpiPen and pulled it out of the box. Before admin, pt said tongue swelling is better so didn't administer. She couldn't hear properly, numbness in hands/legs, & stiff hands.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Loss of consciousness
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IN
- Alter
- 11,0
- Geschlecht
- M
- Eingang
- 23.07.2021
- Impfdatum
- 12.07.2021
- Beginn
- 23.07.2021
- Tage bis Beginn
- 11,0
- Dosis
- UNK
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Encephalitis
Pyrexia
Tremor
Urinary incontinence
Symptomtext
Admitted to PICU with acute onset encephalitis. He had Tdap and Meninococcal vaccines for school on July 12, 2021, 5 days post vaccination he became febrile. fever occurred in evening and spontaneously resolved. Mom noticed 3 days prior to presentation that he was walking funny and was confused. Patient had temperature of 100.8 degrees on Tuesday night and then 100.3 degrees last night. She said he had episodes of tremoring and therefore took him to neighborhood Hospital for evaluation. While he was there he had episode of Urinary incontinence. Patient does not have any history of seizures and no family history of seizures.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Tremor
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Hashimoto's thryoiditis (May 2020)
- Andere Medikamente
- Levothyroxine 75mcg Qday. Topical cr for cutaneous fungal rash
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 16,0
- Geschlecht
- M
- Eingang
- 08.06.2021
- Impfdatum
- 08.06.2021
- Beginn
- 08.06.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Blood glucose normal
Chest pain
Fall
Symptomtext
Patient received MCV4 vaccine #2 dose around 11:15am on June 8, 2021 while sitting on corner of exam table. About 11:20am, patient suddenly fell forward from exam table and hit the floor face down while MA and mom present in room and assisted him further. Vitals were taken and stable. Patient remained alert and oriented. Patient was able to arise from floor and sit up on exam table and was further examined by Dr. and FNP. Patient started to experience chest pain within a few minutes and 911 was dispatched at 1136am. Patient has remained alert and oriented through exam and upon arrival of EMS/Fire Dept around 11:45am and vitals remained stable. Ambulance with paramedics arrived around 11:55am and vitals remained stable. After the EMS/Fire Dept and Paramedics discussed mom the different options of going to ER by ambulance or Private vehicle, mother chose Private vehicle. Patient walked out of Dr office around 12:09 pm to private vehicle while being escorted by mom and Fire EMS personnel. Mom was going to take patient to Local ER for further evaluation.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chest pain
- Hospital-Tage
- -
- Labordaten
- BP 134/82- Pulse 69- RR24, 98.9 Temp, O2saturation on room air 98%. Blood sugar 114.
- Aktuelle Erkrankungen
- None per mom
- Vorgeschichte
- None per mom
- Andere Medikamente
- None per mom
- Allergien
- No known allergies per mom
- Vorherige Impfungen
- -
- Staat
- AK
- Alter
- 10,0
- Geschlecht
- F
- Eingang
- 03.03.2023
- Impfdatum
- 11.10.2021
- Beginn
- 01.10.2021
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site induration
Injection site mass
Injection site pain
Symptomtext
PATIENT DEVELOPED PAIN AND INDURATION AT INJECTION SITE THE DAY AFTER TDAP IMMUNIZATION WAS GIVEN. THIS MASS HAS REMAINED AT INJECTION SITE FOR 17 MONTHS AND IS STILL TENDER TO PALPATION.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site induration
- Hospital-Tage
- -
- Labordaten
- NONE
- Aktuelle Erkrankungen
- NONE
- Vorgeschichte
- CONSTIPATION, MIGRAINE HEADACHES
- Andere Medikamente
- MULTI-VITAMIN, MIRALAX
- Allergien
- NONE
- Vorherige Impfungen
- -
- Staat
- MD
- Alter
- 16,0
- Geschlecht
- M
- Eingang
- 22.10.2021
- Impfdatum
- 20.10.2021
- Beginn
- 20.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Decreased appetite
Dizziness
Fatigue
Feeling of body temperature change
Pain in extremity
Panic reaction
Tachypnoea
Tinnitus
Symptomtext
1 hour after vaccination at home, patient reported to mother that he felt extremely dizzy and had fast breathing/panic attack-like symptoms. Felt hot and cold but afebrile. Told to go to bed and rest and later woke up complaining of feeling ringing in ears then no sound for about 30 seconds then back to normal. The next day still felt dizzy and fatigued. Limited appetite, no rash, no vomiting, no fevers. Left arm aching. Seems to be improving.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dizziness
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Seasonal allergies
- Andere Medikamente
- -
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 12,0
- Geschlecht
- F
- Eingang
- 21.10.2021
- Impfdatum
- 06.10.2021
- Beginn
- 06.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Chest discomfort
Culture throat negative
Dizziness postural
Electrocardiogram
Headache
Nausea
SARS-CoV-2 test negative
Streptococcus test negative
Symptomtext
2 day headache when laying down, x 4 days Dizziness when standing x 4 days Nausea x 1 day Chest tightness
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dizziness postural
- Hospital-Tage
- -
- Labordaten
- 10/9/21 Rapid strep - Negative, Throat culture, Negative, COVID-19-Negative, EKG ordered, cardiology referral placed
- Aktuelle Erkrankungen
- Concern for lactose intolerance
- Vorgeschichte
- Port wine stain - right anterior calf, Depression
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 12,0
- Geschlecht
- M
- Eingang
- 21.10.2021
- Impfdatum
- 18.10.2021
- Beginn
- 18.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Body temperature increased
Chills
Erythema
Skin warm
Swelling face
Vomiting
Symptomtext
Per patient's mother patient was noted with swelling/redness to face primarily the cheeks, skin hot to the touch and chills about 8PM 10/18/2021. Around 1:00AM 10/19/2021 they called EMS and he was taken to the hospital. On the way to the hospital he vomited once in the ambulance. Patient's temperature was 103.4 at the hospital and was given Tylenol and Motrin. He was discharged after evaluation. Mother unaware of any other medications/treatment/diagnosis given at the hospital.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chills
- Hospital-Tage
- -
- Labordaten
- Unknown per patient's mother
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 12,0
- Geschlecht
- M
- Eingang
- 19.10.2021
- Impfdatum
- 20.09.2021
- Beginn
- 20.09.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Blister
Cough
Headache
Heart rate increased
Nausea
Pyrexia
Respiratory tract congestion
Urticaria
Vomiting
Symptomtext
Initially, headache, fever to 103F for two days. Elevated heart rate, nausea, vomiting, cough congestion and subsequently severe hives and blistering all over body that still persist currently. Hives have abated, but blisters still come and go especially on opposite arm of vaccination. Original blister has persisted throughout course never abating. It is located on right shoulder. Oval in shape, 1 x 1.5 inches.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Headache
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- migraine onset age 6 years, Lyme disease age 11 years (currently asymptomatic), MTHFR ( methylenetetrahyrofolate reductase mutation)
- Andere Medikamente
- none
- Allergien
- eggs, anything in the mold/fungus family, turkey, sugar, chromium, iron, vitamin-c
- Vorherige Impfungen
- cough, rhinorrhea, fever over 101, headache, hives, ten years of age, 09/05/2019, Tdap, Adacel (U6401AA lot #)
- Staat
- NY
- Alter
- 17,0
- Geschlecht
- M
- Eingang
- 18.10.2021
- Impfdatum
- 12.10.2021
- Beginn
- 12.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Bone pain
Erythema
Headache
Injection site swelling
Lethargy
Fatigue
Myalgia
Pyrexia
Tenderness
Symptomtext
Lethargic, headache, deep muscle aches, deep bone ache, slight fever (99), sight of injection is swollen, Red, hot, sensitive to touch
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Fatigue
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- Vitamin D
- Allergien
- Unknown
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 12,0
- Geschlecht
- M
- Eingang
- 14.10.2021
- Impfdatum
- 13.10.2021
- Beginn
- 14.10.2021
- Tage bis Beginn
- 1,0
- Dosis
- UNK
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Pain
Pruritus
Urticaria
Symptomtext
Large hives all over body - itch and hurt
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pain
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 16,0
- Geschlecht
- M
- Eingang
- 29.09.2021
- Impfdatum
- 29.06.2021
- Beginn
- 30.06.2021
- Tage bis Beginn
- 1,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Pain in extremity
Peripheral swelling
Symptomtext
Per patient experienced swelling to Right arm with pain. On next visit 08/11/2021 father reporter reaction.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pain in extremity
- Hospital-Tage
- -
- Labordaten
- Advised to follow up if any other symptoms appeared.
- Aktuelle Erkrankungen
- NONE
- Vorgeschichte
- NONE
- Andere Medikamente
- NONE
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 12,0
- Geschlecht
- F
- Eingang
- 28.09.2021
- Impfdatum
- 28.09.2021
- Beginn
- 28.09.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Malaise
Nausea
Supine position
Symptomtext
At 12:26 PM, the patient's parent alerted the nurses station that the patient was "not feeling well," and complaining of nausea. Initial blood pressure at 12:26 PM was 85/50, pulse 81. Patient alert, oriented, and responsive. Patient was immediately positioned supine on the exam table and patient's feet were elevated. Patient was given a granola bar and a cup of water. At 12:28 PM, blood pressure was 85/59, patient complained of nausea. At 12:30 PM, blood pressure was 104/70, pulse 79. At 12:32 patient's blood pressure was 100/63. Patient was monitored for several minutes. Patient stated she "felt better." At 12:40 blood pressure was 93/63. At 12:56, blood pressure was 97/62. Patient denied complaints of nausea, dizziness, numbness, shortness of breath. Patient discharged. Follow up call placed at 6:00PM, no answer.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Malaise
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 12,0
- Geschlecht
- F
- Eingang
- 26.08.2021
- Impfdatum
- 25.08.2021
- Beginn
- 25.08.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Pruritus
Rash
Rash erythematous
Rash papular
Urticaria
Symptomtext
Mother states child came home from school yesterday c/o itch and breaking out. Mother brings child by for evaluation to see if r/t the vaccines. On exam, noted wheals, raised and red with a prominent puncture mark in the center. Wheals are localized to the back, hip, and gluteal areas, beginning at the thoracic region of the spine down to the gluteus maximus. There are 9 wheals on her back, 3 on right hip, 1 on left hip, and 6 on right gm, ranging in size from 1/2"-1" in diameter. Each one has a distinct center such as a bug bite would. Denies any other symptoms. Mother states child was in the woods the evening before her shots playing hide and seek with 3 other friends, but none of those 3 have similar s/s. Mom has been using OTC cortisone cream on areas, which helps temporarily but comes back. No other treatments attempted. Mother thinks it might actually be chiggers from the woods, but wanted to make sure. All 3 injection sites are free of any symptoms, skin is pink, nontender to touch, normal temperature to touch. No redness or reaction of any kind at the injection sites.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pruritus
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- NONE
- Vorgeschichte
- NONE
- Andere Medikamente
- NONW
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 11,0
- Geschlecht
- M
- Eingang
- 18.08.2021
- Impfdatum
- 16.08.2021
- Beginn
- 18.08.2021
- Tage bis Beginn
- 2,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site erythema
Injection site swelling
Injection site warmth
Pain
Tenderness
Symptomtext
redness, warmth, and swelling to Right arm at injections site. Tender to touch and with movement
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- family history of diabetes, BMI > 95th percentile
- Andere Medikamente
- n\a
- Allergien
- n/a
- Vorherige Impfungen
- -
- Staat
- VA
- Alter
- 12,0
- Geschlecht
- M
- Eingang
- 13.08.2021
- Impfdatum
- 11.08.2021
- Beginn
- 11.08.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Dizziness
Feeling hot
Hypophagia
Symptomtext
Recipient began feeling warm and getting lightheaded after being vaccinated. Recipient and mom verbalized he had not eaten all day. The recipient laid down with feet up and was given water. Recipient started feeling better. Recipient was kept for 30 minutes to monitor and verbalized felt much better. RN's advised mom to get recipient food and encouraged fluid intake. No further issues or concerns to report.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dizziness
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 16,0
- Geschlecht
- F
- Eingang
- 28.07.2021
- Impfdatum
- 20.07.2021
- Beginn
- 20.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site pain
Neck pain
Pain
Pain in extremity
Symptomtext
Patient is a 16 year old female here with mother, complaining of right deltoid pain since MCV4 and Men B vaccination on 07/20. Injection pain up to her neck, later radiating down to wrist. No medication yet.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site pain
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NV
- Alter
- -
- Geschlecht
- U
- Eingang
- 02.08.2023
- Impfdatum
- 16.06.2022
- Beginn
- 16.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Medication error
No adverse event
Symptomtext
Menactra vaccine was given on 6/16 and it expired on 6/9 (7 days expired) with no reported adverse event; Initial information received on 27-Jul-2023 regarding an unsolicited valid non-serious case received from a physician. This case involves an unknown age and unknown gender patient for whom Meningococcal A-C-Y-W135 (D CONJ) vaccine [Menactra] vaccine was given on 6/16 and it expired on 6/9 (7 days expired) with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 16-Jun-2022, the patient received a 7 day expired dose of suspect Meningococcal A-C-Y-W135 (D CONJ) vaccine solution for injection (dose, strength unknown) (lot: U6952AA, Expiry: 09-Jun-2023) via unknown route in unknown administration site for prophylactic vaccination (Immunisation) with no reported adverse event (expired product administered) (latency: same day). Action taken: not applicable. At time of reporting, the outcome was Unknown. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NV
- Alter
- 12,0
- Geschlecht
- M
- Eingang
- 12.12.2022
- Impfdatum
- 16.06.2022
- Beginn
- 01.06.2022
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
No adverse event
Vaccination error
Symptomtext
Vaccine administration error There was no adverse events that occurred, no treatment, signs or symptoms.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- MA
- Alter
- 22,0
- Geschlecht
- M
- Eingang
- 12.09.2022
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Medication error
No adverse event
Symptomtext
nurse administered an expired menactra to a patient with no reported adverse event; Initial information received on 25-Aug-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 22 years old male patient who was administered an expired menactra with no reported adverse event , after receiving vaccine MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE [MENACTRA]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient received a dose of suspect MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE ( lot U6952AA and expiarion date: 09-Jun-2022) at a dose 0f 0.25ml via intramuscular route in the left deltoid for immnuization. On an unknown date , the patient administered an expired menactra with no reported adverse event (expired product administered) (latency: same day) following the administration of MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE. Action taken: not applicable. Outcome: unknown This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 16,0
- Geschlecht
- M
- Eingang
- 09.08.2022
- Impfdatum
- 03.08.2022
- Beginn
- 03.08.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
administered Menactra after the expiration date with no reported adverse event; Initial information received on 03-Aug-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 16 years old male patient who was administered MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE (Menactra) after the expiration date with no reported adverse event The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications were reported as none On 03-Aug-2022, the patient received a dose 2 of suspect MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE, at dose of 0.5 ml once, ( lot: U6952AA ; expiry date: 09-Jun-2022) via intramuscular route in the left deltoid for immunization. It was reported that the patient was administered Menactra after the expiration date with no reported adverse event (expired product administered) (onset date: 03-Aug-2022) (latency: same day) following the administration of MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE. Action taken : not applicable. Outcome: unknown This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IA
- Alter
- 17,0
- Geschlecht
- F
- Eingang
- 08.08.2022
- Impfdatum
- 26.07.2022
- Beginn
- 26.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
administered expired menactra with no reported adverse event; Initial information received on 02-Aug-2022 regarding an unsolicited valid non-serious case received from health professional. (GMI number: 01217750) This case is linked to case A200410725. This case involves a 17-year-old female patient who had administered expired Meningococcal A-C-Y-W135 (D CONJ) Vaccine [Menactra] with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 26-Jul-2022, the patient administered expired Menactra vaccine 0.5 ml once lot U6952AA via unknown route in the right arm for Immunization with no reported adverse event (expired product administered, latency same day). It was reported that Office manager report a MA administered expired MENACTRA. She states no side effects have been noted. She would like to know if the patient needs to be re-dosed. Action taken: Not applicable. At time of reporting, the outcome was Unknown. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 20,0
- Geschlecht
- M
- Eingang
- 24.07.2022
- Impfdatum
- 13.07.2022
- Beginn
- 13.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
expired MENACTRA being administered to a patient, with no adverse event; Initial information received on 13-Jul-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 20 years old male patient who was administered expired Meningococcal A-C-Y-W135 (D CONJ) Vaccine [Menactra], with no adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 13-Jul-2022, the patient received (0.5 mL 1X) dose of suspect Meningococcal A-C-Y-W135 (D CONJ) Vaccine (lot U6952AA; expiry date; 09-Jun-2022, strength, formulation not reported) via intramuscular route in the left deltoid for immunization. On 13-Jul-2022 (latency: same day) the patient developed a non-serious expired menactra being administered to a patient, with no adverse event (expired product administered). Action taken: Not applicable. Outcome: Unknown This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 20,0
- Geschlecht
- F
- Eingang
- 03.07.2022
- Impfdatum
- 01.06.2019
- Beginn
- 01.06.2022
- Tage bis Beginn
- 1.096,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
they inadvertently gave an expired MENACTRA vaccine to a patient with no reported adverse event; Initial information received on 21-Jun-2022 regarding an unsolicited valid non-serious case received from nurse. GMI number: 01156569 This case involves a 20-year-old female patient to whom inadvertently expired Meningococcal A-C-Y-W135 (D CONJ) Vaccine [Menactra] vaccine was given with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. In June 2019, the nurse inadvertently gave patient dose of suspect Menactra (lot U6952AA, expiry date: 09-Jun-2022) at (unknown: formulation, strength, dose, route, site) for prophylactic vaccination (expired product administered, same day latency). It was reported that "nurse states they inadvertently gave an expired MENACTRA vaccine to a patient. Is this dose valid or what do they need to do at this point? MIA transferred nurse who asks if a dose of Menactra which expired 09JUN2022 would need to be repeated? This situation is reported as a medication error due to expired vaccine given". Action taken: Not applicable. At time of reporting, the outcome was Unknown for the event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MD
- Alter
- 17,0
- Geschlecht
- M
- Eingang
- 03.07.2022
- Impfdatum
- 17.06.2022
- Beginn
- 17.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
expired MENACTRA was administered to a patient with no reported adverse event; Initial information received on 17-Jun-2022 regarding an unsolicited valid non-serious case received from a other health professional via call canter. This case involves a 17 years old male patient who experienced expired menactra was administered to a patient with no reported adverse event while receiving vaccine Meningococcal A-C-Y-W135 (D Conj) Vaccine [Menactra]. The patient's past medical history, medical treatment(s), vaccination(s), concomitant medication(s) and family history were not provided. On 17-JUN-2022, the patient received a 0.5 ml (total) dose of suspect meningococcal a-c-y-w135 (d conj) vaccine lot U6952AA, expiry date: 09-Jun-2022 (strength, formulation, frequency: unknown) via intramuscular route in the left deltoid as Immunization. On 17-JUN-2022 the patient developed a non-serious event expired menactra was administered to a patient with no reported adverse event (expired product administered) (latency same day) following the administration of meningococcal a-c-y-w135 (d conj) vaccine. Action taken was not applicable. It was not reported if the patient received a corrective treatment for the event (expired product administered). At time of reporting, the outcome was Unknown for the event expired product administered. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- VA
- Alter
- 19,0
- Geschlecht
- M
- Eingang
- 03.07.2022
- Impfdatum
- 17.06.2022
- Beginn
- 17.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
accidentally gave a patient expired MENACTRA with no reported adverse event; Initial information received on 17-Jun-2022 regarding an unsolicited valid non-serious case received from a other health professional via call center This case involves a 19 years old male patient who experienced accidentally gave a patient expired menactra with no reported adverse event while receiving meningococcal a-c-y-w135 (d conj) vaccine [Menactra]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 17-Jun-2022, the patient received a 0.5 ml dose of suspect meningococcal a-c-y-w135 (d conj) vaccine (batch lot number : U6952AA,Expiry date :09-Jun-2022)(unknown strength) via intramuscular route in the right deltoid. On 17-Jun-2022 (latency :same day) the patient developed a non-serious event of accidentally gave a patient expired menactra with no reported adverse event (expired product administered) following the administration of meningococcal a-c-y-w135 (d conj) vaccine. Action taken : not applicable. At time of reporting, the outcome was Unknown for the event . This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 11,0
- Geschlecht
- M
- Eingang
- 29.06.2022
- Impfdatum
- 29.06.2022
- Beginn
- 29.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
Administered an expired vaccine. The expiration date on the vaccine was dated 06/09/2022. Pt had no sxs after injection.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- n/a
- Vorherige Impfungen
- -
- Staat
- OR
- Alter
- -
- Geschlecht
- U
- Eingang
- 21.06.2022
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Accidental exposure to product
No adverse event
Symptomtext
Product was accidentally administered to ta patient,with no reported adverse event; Initial information received f on 14-Jun-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case involves patient (unknown age and gender) who experienced product was accidentally administered to ta patient,with no reported adverse event while receiving vaccine MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE [MENACTRA]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient received a dose of suspect MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE (lot U6952AA; expiry date:09-Jun-2022) (strength, dose, formulation, route: unknown) in unknown administration site for prophylactic vaccination. On an unknown date the patient reported product was accidentally administered to ta patient,with no reported adverse event (accidental exposure to product) (unknown latency) following the administration of MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE. Action taken: not applicable. At time of reporting, the outcome was Unknown for the event product was accidentally administered to ta patient,with no reported adverse event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Accidental exposure to product
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OR
- Alter
- 13,0
- Geschlecht
- F
- Eingang
- 17.06.2022
- Impfdatum
- 13.06.2022
- Beginn
- 13.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Expired product administered
Symptomtext
LPN inadvertently administered Menactra vaccine that was 4 days past expiration, Pt showed no obvious sings of ASE r/t expired dose of vaccine, LPN reported inadvertent administration to provider right away, LPN called manufacture and manufacture stated that There is no contraindications from the CDC regarding expired vaccine at this time, Manufacture stated that the pt will need to repeat vaccine as soon as possible, LPN called and spoke with Pt legal guardian and explained what had happened, Pt legal guardian stated that the pt appeared to be normal and had no complaints regarding expired vaccine.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- NC
- Alter
- 12,0
- Geschlecht
- F
- Eingang
- 13.06.2022
- Impfdatum
- 13.06.2022
- Beginn
- 13.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Expired product administered
Symptomtext
The vaccine had expired by 4 days when given to the patient
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- n/a
- Vorgeschichte
- n/a
- Andere Medikamente
- n/a
- Allergien
- n/a
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 70,0
- Geschlecht
- F
- Eingang
- 06.06.2022
- Impfdatum
- 18.01.2022
- Beginn
- 18.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Inappropriate schedule of product administration
No adverse event
Symptomtext
reported that a patient received 2 doses of MENACTRA at 4 weeks apart, instead of the recommended 8 weeks apart with no reported adverse event; Initial information received on 31-May-2022 regarding an unsolicited valid non-serious case received from a other health professional via call center. This case involves a 70 years old female patient who experienced reported that a patient received 2 doses of menactra at 4 weeks apart, instead of the recommended 8 weeks apart with no reported adverse event while receiving vaccine Meningococcal A-C-Y-W135 (D Conj) Vaccine [Menactra]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included Eculizumab (Soliris). On 18-Jan-2022, the patient received 0.5 ml dose of suspect meningococcal a-c-y-w135 (d conj) vaccine lot U6952AA Expiration date: 09-Jun-2022, frequency: once, unknown strength and formulation via intramuscular route in the left deltoid as immunization and received same vaccine at the interval of 4 weeks with unknown batch lot, route, administration site, frequency, formulation and expiry date. On 18-JAN-2022 the patient developed a non-serious event reported that a patient received 2 doses of menactra at 4 weeks apart, instead of the recommended 8 weeks apart with no reported adverse event (inappropriate schedule of product administration) latency: unknown following the administration of meningococcal a-c-y-w135 (d conj) vaccine. Action taken was not applicable. It was not reported if the patient received a corrective treatment for the event (inappropriate schedule of product administration). At time of reporting, the outcome was Unknown for the event inappropriate schedule of product administration. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- SOLIRIS
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NC
- Alter
- 17,0
- Geschlecht
- F
- Eingang
- 18.05.2022
- Impfdatum
- 16.05.2022
- Beginn
- 16.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Inappropriate schedule of product administration
Symptomtext
Patient was given ProQuad and Menactra together.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- Zyrtec
- Allergien
- tree nuts
- Vorherige Impfungen
- -
- Staat
- NC
- Alter
- 17,0
- Geschlecht
- F
- Eingang
- 18.05.2022
- Impfdatum
- 16.05.2022
- Beginn
- 16.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Inappropriate schedule of product administration
No adverse event
Symptomtext
Patient was mistakenly given ProQuad and Menactra together. At this time she is not experiencing an adverse reaction. Called to report and was advised to fill out this VAERS form.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- Zyrtec
- Allergien
- tree nuts
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 18,0
- Geschlecht
- F
- Eingang
- 21.04.2022
- Impfdatum
- 14.04.2022
- Beginn
- 14.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Incorrect route of product administration
Medication error
No adverse event
Symptomtext
administered Menactra to a patient subcutaneously instead of intramuscularly with no reported adverse event; Initial information received on 14-Apr-2022 regarding an unsolicited valid non-serious case received from a Nurse. This case involves a 18 years old female patient who had administered menactra to a patient subcutaneously instead of intramuscularly with no reported adverse event while receiving vaccine meningococcal a-c-y-w135 (d conj) vaccine [Menactra]. The patient's past medical history, medical treatment(s), concomitant medication, vaccination(s) and family history were not provided. On 14-Apr-2022, the patient received 0.5ml dose of suspect meningococcal a-c-y-w135 (d conj) vaccine (frequency, strength was unknown, lot U6952AA and expiry date: 09-Jun-2022) via subcutaneous route in unknown administration site for prophylactic vaccination. It was reported that Patient last menstrual period was on 25-Mar-2022. On 14-Apr-2022, (Latency: same day) Nurse administered menactra to a patient subcutaneously instead of intramuscularly with no reported adverse event (incorrect route of product administration) and they just want to know what to do moving forward. Nurse just wants to know if the dose needs to be repeated. Action taken : not applicable. Outcome: Unknown This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect route of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CT
- Alter
- 12,0
- Geschlecht
- M
- Eingang
- 30.03.2022
- Impfdatum
- 30.03.2022
- Beginn
- 30.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Extra dose administered
Symptomtext
Patient received a 3rd dose of Hepatitis A vaccine when he only needed 2.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- None
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 17,0
- Geschlecht
- F
- Eingang
- 27.09.2021
- Impfdatum
- 27.09.2021
- Beginn
- 27.09.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Erythema
Symptomtext
redness to left arm
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Erythema
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- Dairy Products
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- 12,0
- Geschlecht
- M
- Eingang
- 08.09.2021
- Impfdatum
- 07.09.2021
- Beginn
- 07.09.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Extra dose administered
Symptomtext
Nurse missed second verification against vaccine record, and administered Meningococcal Conjugate vaccine to patient before the second dose was recommended thinking it was the initial dose. Nurse caught the administration error, and discussed with patient and father at the time. Explaining that there would be no side effects because of the additional dose, but that it did not count towards the series, and patient would still require a second dose at a later time.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- n/a
- Vorgeschichte
- n/a
- Andere Medikamente
- n/a
- Allergien
- n/a
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 12,0
- Geschlecht
- M
- Eingang
- 29.08.2021
- Impfdatum
- 31.07.2021
- Beginn
- 31.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Incorrect dose administered
No adverse event
Product preparation issue
Symptomtext
the patient technically got half a Menactra dose because the patient received 0.5 mL of the diluted solution/no AE; accidentally diluted Menactra with the sterile diluent that was used with the MMR and Varicella/no AE; Initial information was received on 02-Aug-2021 regarding an unsolicited valid non-serious case received from a Nurse via the [Global Medical Information (GMI) under reference-00706608]. This case involves a 12 year-old male patient who accidentally got half of the MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE [MENACTRA] (0.5 mL of the diluted solution) which was diluted with the sterile diluent that was used with the MMR and Varicella (underdose) (product preparation error). The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included DIPHTHERIA VACCINE TOXOID, PERTUSSIS VACCINE ACELLULAR, TETANUS VACCINE TOXOID (TDAP) for prophylactic vaccination. On 31-Jul-2021, the patient received 0.5 mL (of diluted vaccine) [once; standard] dose of suspect MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE (lot U6952AA and expiry date 09-Jun-2022) via an intramuscular route in the right deltoid for prophylactic vaccination. It was a case of an actual medication error due to vaccine underdose (latency was on same day). It was a also a case of inappropriate reconstitution technique. It was reported that "NP asking if they need to repeat the MENACTRA dose. NP states that the patient technically got half a MENACTRA dose because the patient received 0.5 mL of the diluted solution (MENACTRA). NP asking if they re-administer the dose if it would be another full dose or if they would give a half of a dose. NP asking if there are certain potential side effects to watch out for since the patient will be receiving a dose and a half total". The patient was fine and there was no type of adverse event. outcome of the event was unknown. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- TDAP
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 12,0
- Geschlecht
- M
- Eingang
- 31.07.2021
- Impfdatum
- 31.07.2021
- Beginn
- 31.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Incorrect product formulation administered
Symptomtext
Patient was in office for MCV4 vaccine, vaccine was diluted with sterile diluent and administered to patient. Patient was notified in office.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect product formulation administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- NKA
- Vorherige Impfungen
- -